Skip to Content

N899 300 (Nizatidine 300 mg)

Pill with imprint N899 300 is Beige, Capsule-shape and has been identified as Nizatidine 300 mg. It is supplied by Teva Pharmaceuticals USA.

Nizatidine is used in the treatment of erosive esophagitis; gerd; duodenal ulcer; stomach ulcer; duodenal ulcer prophylaxis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for N899 300

Nizatidine

Imprint:
N899 300
Strength:
300 mg
Color:
Beige
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide